Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Monolaurin vs Mupirocin for Pediatric Skin Infections
NCT06046937Phase 1Completed
- Sponsor
- Victoriano Luna Medical Center
- Start
- Jun 2023
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of monolaurin in bacterial skin infection (2 arms), sponsored by Victoriano Luna Medical Center. Primary endpoint: Success or Failure of Therapy at 7 days. Started Jun 2023; status: completed.
02
Drugs
monolaurin
03
Conditions
bacterial skin infection
Beyond the preview
Go deeper on NCT06046937.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06046937.